On-demand webinar: Mitigating risk in mRNA manufacturing when transitioning from preclinical to clinical

Join Evan Myers, head of TriLink GMP services' process development team, as he discusses key challenges and solutions in the pivotal transition stages of mRNA manufacturing.

Key topics to be discovered:

Understand how mRNA as a versatile platform for therapeutic and vaccine development holds immense promise in reshaping the landscape of molecular medicine.
Learn about common challenges with preclinical and clinical transitions in mRNA manufacturing
Explore how to mitigate risk and streamline mRNA manufacturing across phases through scale-up, process robustness, and reproducibility
Discover practical takeaways for researchers and developers working on mRNA technologies

Get access to the webinar and watch it anytime, anywhere

Complete the form below to get access to the webinar recording

On Demand Webinar: Mitigating risk in mRNA manufacturing when transitioning from preclinical to clinical

On Demand Webinar

Country Name

Country

Ship to State Name

Ship to State

Postal code

First Name

Last Name

Work Email

Phone number

Company/Institution

Job Title

Opt in

I would like to be connected to a sales specialist to learn about products and services to support my mRNA project.

Opt in

Yes, I would like to receive emails to stay informed about updates from TriLink Biotechnologies, including webinars, new product releases, and upcoming events.

TriLink BioTechnologies does not sell or distribute your information to 3rd parties. For more information, please refer to our Privacy Policy.

On-demand webinar: Mitigating risk in mRNA manufacturing when transitioning from preclinical to clinical

Key topics to be discovered:

Get access to the webinar and watch it anytime, anywhere

On Demand Webinar: Mitigating risk in mRNA manufacturing when transitioning from preclinical to clinical

The hottest topics and cutting-edge research—straight to your inbox.

Email Sign Up